Work

Molecular insights for overcoming Hepatocellular Carcinoma

Year: 2012
Type: dissertation
Abstract: SUMMARY \n \n \nIntroduction. Hepatocellular Carcinoma (HCC) ranks fifth in frequency of cancers in the world. Orthotopic Liver Transplantation (OLT) or liver resection represents the best treatments for HCC. However, most patients cannot be subjected to potential curative OLT or resection because of extensive tumor involvement of the liver, metastasis, invasion of the portal vein or advanced underlying hepatocellular disease at the time of diagnosis. Systemic chemotherapy or chemoembolization represent a good alternative for the treatment, however drug therapy of cancer in general is hampered by multidrug resistance (MDR) that is a phenomenon caused by the up-regulation of the ABC-transporters (ABC) leading to chemotherapy failure. \nTo overcome these problems new therapeutic approaches, such gene therapy, are needed. Selective down-regulation of an essential and specific cancer gene such as telomerase (hTERT) could represent an emerging strategy that could prevent cancer progression and diminish numerous side effects derived from drug usage. \nThe present study include two tasks whose aims are: \nTask 1: a) Assess if the extent of tumoral differentiation results in a different ABCB1, ABCC1 and ABCG2 expression. \nb) Assess whether the treatment with a chemotherapeutic drug(s) may affect the expression of the three ABC transporters under study. \nTask 2: To overcome the obstacle of MDR-induced chemoresistance using new therapeutic approaches such as gene therapy, silencing a cancer essential and specific gene. \nResults and discussion. Task 1: We assessed the ABCB1, ABCC1 and ABCG2 expression in three hepatic cell lines: IHH (non tumoral control), HuH7 (differentiated tumoral cells) and JHH6 (undifferentiated tumoral cells). Only ABCG2 expression correlates with the degree of tumoral differentiation. \nThrough confocal microscopy analysis we observed that the Doxorubicin (Dox) is able to reach the cell’s nucleus within 10 min. After 24h and 48h Dox is completely concentrated into the nucleus where some nuclear damage occurs. The presence of damaged nuclei could explain the decreased mRNA in most of the ABCs under study. The treatment with Dox doses lower than the LC50 for 24h and 48h has different consequences for all the ABC considered in the three cell lines, with an mRNA expression pattern not in line with the protein one in most of the cases, suggesting that the possible mechanism that determines the ABCs protein upregulation in the tumoral cell lines (HuH7 and JHH6) is not the de-novo transcription but probably something related to the protein turnover. \nAfter the treatment ABCC1 protein expression increases in the tumoral cell lines but not in the non tumoral one (IHH). Regarding ABCB1 and ABCG2, these transporters seem to play a role only in HuH7 and JHH6 cells respectively. We were not able to correlate the tumorigenic potential of the two tumoral cell lines with the ABC expression since the different behaviour of ABCs and the different contribution to MDR. Thus in order to better clarify the contribution of each single ABC to MDR our future steps will consider the use specific inhibitors. \nTask 2: From our in vivo data, among four cancer related genes we selected hTERT as the best candidate for silencing experiments due to its exclusive expression in tumoral samples. A functional non-inflammatory siRNA targeting hTERT was designed: SirTel 1. \nSilencing experiments were conducted in JHH6 cell line. The hTERT silencing effect was dose dependent, at least at the three considered doses (25-50-100nM). For all the subsequent determinations the experimental concentration was 25nM. After 72h of silencing we observed a significant reduction in both hTERT mRNA expression and enzymatic activity (p<0.001). \nThe effects observed in the cells after silencing are: \n-\tMorphological changes, from a fibroblast-like to an hepatocyte-like shape; \n-\tIncreased albumin expression. The expression of this hepatic hallmark increases after silencing in JHH6 cells that, due to their poor degree of differentiation, at basal conditions do not express quantifiable levels of albumin. The peak of the higher albumin expression corresponds to the maximum hTERT silencing effect. \n-\tDecreased cell viability (p<0.01). Interestingly, the siRNA induced a reduction in cell viability higher than Dox. \n-\tCell cycle arrest in G1 phase (p<0.01). \nAll data were validated using a hTERT negative cell line (primary culture of human fibroblast). \nAfter 72h silencing, we observed that hTERT expression reaches its minimum, and the expression is recovered after 264h although it does not reach the initial expression levels. Re-exposing the cells to additional 25nM of siRNA induces a reduction of mRNA levels by 76% compared to the amount already present after the first treatment. \nTaken together all this results suggest the pivotal role of hTERT silencing in a HCC derived cell line. Therefore, hTERT represent a promising candidate for gene-therapy strategies in HCC.
Author: Devis Pascut
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W1562119965
Cites: 360
Cited by:
Related to: 10